We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Siemens Healthineers Launches Thermocycler with AI-Powered Software

By LabMedica International staff writers
Posted on 26 Apr 2018
Siemens Healthineers (Erlangen, Germany) launched a new molecular thermocycler, the Fast Track cycler (FTC), and the complementary new FastFinder software at the 28th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2018). More...
The compact FTC allows laboratories of all sizes to implement molecular testing with simplicity and speed, while the FastFinder software improves workflow using Artificial Intelligence (AI)-powered automation.

Weighing two kilograms and measuring 150 mm x 150 mm x 130 mm, the FTC is a scalable platform, allowing up to 10 thermocyclers to be connected to one computer and permitting laboratories to utilize a range of 1 to 480 wells. The FTC uses magnetic induction technology to deliver robust and reliable results, and does not require calibration, as a result of which it does not drift or age and offers simple handling. The FTC is also equipped with the Fast Track lyophilised technology, offering reagents for PCR experiments in a single sample tube, simplifying processes for users by eliminating the need to prepare the reaction mix before test implementation. The technology allows users to simply add nucleic acid extracts to the prepared tubes before inserting into the cycler.

Siemens Healthineers, in collaboration with UgenTec, also launched FastFinder software, which is a fully automated real-time PCR interpretation platform that is compatible with all multiplexing kits from Fast Track Diagnostics. The software allows users to fully automate and standardize analysis of kits with the Applied Biosystems 7500 and LightCycler 480 PCR platforms. FastFinder uses its built-in statistical machine learning models to accurately analyze every amplification curve, then automatically combines these results and processes them through an assay-specific decision tree, leading to overall and conclusive results.

With automated plate detection, Laboratory Information Management System (LIMS) connection, and a user-friendly interface, FastFinder is easy-to-use and requires limited training. All assay parameters come pre-set for speed and ease of implementation, and clear, customizable reports allow easy reading of results. The audit trail of analysis, integrated archive, and simultaneous analysis of multiple run files results in improved monitoring and enables users to provide patients with the relevant treatment more quickly.

“Enabled by AI, FastFinder software minimizes the need for manual processing, which not only saves time, but increases the reliability of results as well,” said Fernando Beils, Head of Molecular Diagnostics, Siemens Healthineers. “Users receive 100% reproducible results in a matter of seconds, improving laboratory workflows and expanding precision medicine."

"Siemens Healthineers' focus on AI aligns perfectly with our vision for FastFinder. The combination of Siemens Healthineers' hardware and assays and our extensible software will guide laboratories globally to simple, accurate, and automated molecular diagnostics," said Steven Verhoeven, CEO at UgenTec.


Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Rheumatoid Factors (RF) Test
Rheumatoid Factors (RF)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.